Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice

Journal of Clinical Investigation

Volumn 116, Issue 9, 2006, Pages 2393-2402

  Bettelli, Estelle ^a   Baeten, Dominique ^b   Jäger, Anneli ^a   Sobel, Raymond A ^c,d   Kuchroo, Vijay K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 17; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; HISTOPATHOLOGY; MOUSE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOGLOBULIN HEAVY CHAINS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MULTIPLE SCLEROSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; NEUROMYELITIS OPTICA; OPTIC NERVE; RECEPTORS, ANTIGEN, T-CELL; SPINAL CORD; SPLEEN; T-LYMPHOCYTES;

EID: 33748319513     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28334     Document Type: Article

References (57)

1. Lassmann, H. 1998. Pathology of multiple sclerosis. In McAlpine's multiple sclerosis. A. Compston, et al., editors. Churchill Livingstone. Hong Kong, People's Republic of China. 323-358.
2. Ghezzi, A., et al. 1999. Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J. Neurol. 246:770-775.
3. Soderstrom, M. 2001. Optic neuritis and multiple sclerosis. Acta Ophthalmol. Scand. 79:223-227.
4. Misu, T., et al. 2002. Pure optic-spinal form of multiple sclerosis in Japan. Brain. 125:2460-2468.
5. Wingerchuk, D.M., and Weinshenker, B.G. 2003. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology. 60:848-853.
6. Wingerchuk, D.M., Hogancamp, W.F., O'Brien, P.C., and Weinshenker, B.G. 1999. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 53:1107-1114.
7. Cree, B.A., Goodin, D.S., and Hauser, S.L. 2002. Neuromyelitis optica. Semin. Neurol. 22:105-122.
8. Lucchinetti, C.F., et al. 2002. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 125:1450-1461.
9. Keegan, M., et al. 2002. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. 58:143-146.
10. Zamvil, S.S., et al. 1986. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature. 324:258-260.
11. Sobel, R.A., Greer, J.M., and Kuchroo, V.K. 1994. Minireview: autoimmune responses to myelin proteolipid protein. Neurochem. Res. 19:915-921.
12. Mendel, I., Kerlero de Rosbo, N., and Ben-Nun, A. 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25:1951-1959.
13. Baron, J.L., Madri, J.A., Ruddle, N.H., Hashim, G., and Janeway, C.A., Jr. 1993. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:57-68.
14. Kuchroo, V.K., et al. 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:4371-4382.
15. Langrish, C.L., et al. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233-240.
16. Park, H., et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-1141.
17. Hjelmstrom, P., Juedes, A.E., Fjell, J., and Ruddle, N.H. 1998. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161:4480-4483.
18. Svensson, L., et al. 2002. A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination. Eur. J. Immunol. 32:1939-1946.
19. Lyons, J.A., San, M., Happ, M.P., and Cross, A.H. 1999. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29:3432-3439.
20. Oliver, A.R., Lyon, G.M., and Ruddle, N.H. 2003. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J. Immunol. 171:462-468.
21. Lyons, J.A., Ramsbottom, M.J., and Cross, A.H. 2002. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 32:1905-1913.
22. Fillatreau, S., Sweenie, C.H., McGeachy, M.J., Gray, D., and Anderton, S.M. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3:944-950.
23. Bettelli, E., et al. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197:1073-1081.
24. Litzenburger, T., et al. 1998. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J. Exp. Med. 188:169-180.
25. Slavin, A.J., et al. 2001. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J. Clin. Invest. 108:1133-1139. doi:10.1172/JCI200113360.
26. Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., and Aloisi, F. 2004. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 14:164-174.
27. Corcione, A., et al. 2005. B-cell differentiation in the CNS of patients with multiple sclerosis. Autoimmun. Rev. 4:549-554.
28. Kuchroo, V.K., et al. 2002. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20:101-123.
29. Bettelli, E., et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector T(H)17 and regulatory T cells. Nature. 441:235-238.
30. Esiri, M.M. 1980. Multiple sclerosis: a quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system. Neuropathol. Appl. Neurobiol. 6:9-21.
31. Baranzini, S.E., et al. 1999. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J. Immunol. 163:5133-5144.
32. Qin, Y., et al. 2003. Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis. Lab. Invest. 83:1081-1088.
33. Owens, G.P., et al. 2003. Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J. Immunol. 171:2725-2733.
34. Lennon, V.A., et al. 2004. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 364:2106-2112.
35. Lennon, V.A., Kryzer, T.J., Pittock, S.J., Verkman, A.S., and Hinson, S.R. 2005. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202:473-477.
36. Lanzavecchia, A. 1985. Antigen-specific interaction between T and B cells. Nature. 314:537-539.
37. Bryant, P., and Ploegh, H. 2004. Class II MHC peptide loading by the professionals. Curr. Opin. Immunol. 16:96-102.
38. Hayglass, K.T., Naides, S.J., Scott, C.F., Jr., Benacerraf, B., and Sy, M.S. 1986. T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cells in vivo. J. Immunol. 136:823-829.
39. Ron, Y., and Sprent, J. 1987. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J. Immunol. 138:2848-2856.
40. Janeway, C.A., Jr., Ron, J., and Katz, M.E. 1987. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J. Immunol. 138:1051-1055.
41. Kurt-Jones, E.A., et al. 1988. The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J. Immunol. 140:3773-3778.
42. Epstein, M.M., Di Rosa, F., Jankovic, D., Sher, A., and Matzinger, P. 1995. Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182:915-922.
43. Townsend, S.E., and Goodnow, C.C. 1998. Abortive proliferation of rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo. J. Exp. Med. 187:1611-1621.
44. Garside, P., et al. 1998. Visualization of specific B and T lymphocyte interactions in the lymph node. Science. 281:96-99.
45. MacLennan, I.C., et al. 1997. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol. Rev. 156:53-66.
46. O'Neill, S.K., et al. 2005. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J. Immunol. 174:3781-3788.
47. Breithaupt, C., et al. 2003. Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 100:9446-9451.
48. Kuhn, R., Rajewsky, K., and Muller, W. 1991. Generation and analysis of interleukin-4 deficient mice. Science. 254:707-710.
49. Lafaille, J.J. 2004. T-cell receptor transgenic mice in the study of autoimmune diseases. J. Autoimmun. 22:95-106.
50. Waldner, H., Whitters, M.J., Sobel, R.A., Collins, M., and Kuchroo, V.K. 2000. Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. Proc. Natl. Acad. Sci. U. S. A. 97:3412-3417.
51. Goverman, J., et al. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell. 72:551-560.
52. Lafaille, J.J., Nagashima, K., Katsuki, M., and Tonegawa, S. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell. 78:399-408.
53. Oldstone, M.B. 1987. Molecular mimicry and autoimmune disease. Cell. 50:819-820.
54. Stefferl, A., et al. 2000. Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. J. Immunol. 165:2859-2865.
55. Pagany, M., et al. 2003. Myelin oligodendrocyte glycoprotein is expressed in the peripheral nervous system of rodents and primates. Neurosci. Lett. 350:165-168.
56. Sonoda, E., et al. 1997. B cell development under the condition of allelic inclusion. Immunity. 6:225-233.
57. Adelmann, M., et al. 1995. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J. Neuroimmunol. 63:17-27.